NASDAQ:APGE | Cash Flow Statement | Apogee Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2022-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$85.85M
2026-03-31-$74.11M-$55.57M-$35.35M$411.17M
2025-12-31-$69.39M-$62.69M$62,000.00-$288.63M$374.95M
2025-09-30-$65.02M
2025-06-30-$66.1M
2025-03-31-$55.34M-$48.48M$4.32M$12.98M$622,000.00
2024-12-31-$67.22M-$67.71M-$1,000.00$46.37M$44.36M
2024-09-30-$49.02M
2024-06-30-$33.82M
2024-03-31-$32.09M-$31.64M$351,000.00-$51.74M$450.52M
2023-12-31-$31.74M-$29.75M-$39.69M-$213,000.00
2023-09-30-$20.84M
2023-06-30-$18.89M
2023-03-31-$12.53M-$10.56M
2022-12-31-$14.01M-$9.19M$158.5M
2022-09-30-$19.66M
2022-06-30-$1.82M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$255.84M-$227.45M$5.15M-$179.57M$396.49M
2024-12-31-$182.15M-$171.17M$1.15M-$300.46M$495.11M
2023-12-31-$83.99M-$74.76M$167,000.00-$273.91M$315.39M
2022-12-31-$39.79M-$16.43M$168.32M